Search clinical trials for: AR-12: (2-Amino-N-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide)
Total 215 results
-
Arno TherapeuticsCompletedLymphoma | Solid TumorsUnited States, United Kingdom
-
Johns Hopkins UniversityPrecision MolecularTerminatedAmyotrophic Lateral SclerosisUnited States
-
University of PennsylvaniaActive, not recruitingBreast Cancer | Breast NeoplasmUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseNot yet recruiting
-
Eisai Co., Ltd.CompletedPartial Onset SeizuresJapan, Korea, Republic of
-
Crimson Biopharm Inc.Not yet recruiting
-
Global Blood TherapeuticsMayo ClinicTerminatedCardio-pulmonary FunctionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Acute Bilineal Leukemia | Acute Biphenotypic LeukemiaUnited States
-
Stanford UniversityActive, not recruitingThyroid Cancer | Anaplastic Thyroid Cancer | Undifferentiated Thyroid CancerUnited States
-
Constellation PharmaceuticalsCompleted
-
Michael WagnerEdgewood Oncology Inc.Not yet recruitingLiposarcoma | MDM2 Gene Amplification | Metastatic Liposarcoma | Unresectable Liposarcoma | Recurrent LiposarcomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
HRH Pharmaceuticals LimitedGALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaboratorsCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Otsuka America PharmaceuticalCompletedAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
HRH Pharmaceuticals LimitedGALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil and other collaboratorsCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid LeukemiaUnited States
-
PfizerTerminatedIschemic StrokeUnited States, Taiwan, Korea, Republic of, India, Germany, Canada, France, Bulgaria, Czech Republic, Hungary
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
PfizerCompletedHealthyUnited States
-
Constellation PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingSezary Syndrome | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | T-Cell Prolymphocytic Leukemia | B-Cell Prolymphocytic LeukemiaUnited States
-
GlaxoSmithKlineWithdrawnVenous ThromboembolismUnited States
-
Walter HanelActive, not recruitingRecurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | T-Cell Non-Hodgkin Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
Merck Sharp & Dohme LLCCompletedObesity and Obesity-related Medical Conditions
-
Merck Sharp & Dohme LLCTerminatedType 2 Diabetes Mellitus | Obesity Type 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCTerminated
-
AstraZenecaCompletedRheumatoid ArthritisUnited Kingdom
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Thomas Jefferson UniversityAbbVieRecruitingMyelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic SyndromeUnited States
-
OHSU Knight Cancer InstitutePfizerTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Children's Oncology GroupNot yet recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm
-
Washington University School of MedicineCompleted
-
Orlando Health, Inc.Forest LaboratoriesWithdrawnOsteomyelitis | Joint InfectionsUnited States
-
PfizerCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
PfizerCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes MellitusUnited States
-
AstraZenecaCompletedRheumatoid ArthritisUnited Kingdom
-
Thomas Jefferson UniversityVerastem, Inc.Active, not recruitingMetastatic Uveal MelanomaUnited States
-
TakedaCompletedAcute Coronary SyndromeUnited States, Belgium, Germany, Bulgaria, India, South Africa, Netherlands, Korea, Republic of, Canada, Chile, Peru, Russian Federation, Argentina, Hungary, Romania, Brazil, Estonia, Serbia, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
PfizerCompletedVenous ThrombosisAustralia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia